Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

MC-Val-Cit-PAB-Amide-TLR7 agonist 4

MC-Val-Cit-PAB-Amide-TLR7 agonist 4 (example 15) is a HER2-TLR7 and HER2-TLR8 immune agonist conjugate[1].

Product Specifications

CAS Number

[2413016-49-4]

UNSPSC

12352005

Target

EGFR; Toll-like Receptor (TLR)

Type

Reference compound

Related Pathways

Immunology/Inflammation; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/mc-val-cit-pab-amide-tlr7-agonist-4.html

Purity

99.39

Solubility

10 mM in DMSO

Smiles

O=C(C=CC1=O)N1CCCCCC(N[C@H](C(N[C@H](C(NC2=CC=C(COC(NC(C)(C)C(NCCOC(C)(C)CN3C(C4=CC=CC=C4N=C5N)=C5N=C3COCC)=O)=O)C=C2)=O)CCCNC(N)=O)=O)C(C)C)=O

Molecular Formula

C52H72N12O11

Molecular Weight

1041.20

References & Citations

[1]Valerie Odegard, et al. Compositions for the treatment of disease with immune stimulatory conjugates. WO2020056008 A1.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

ErbB2/HER2; TLR7; TLR8

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

Hsa-miR-3170 agomir
HY-R00626A-01 5 nmol

Hsa-miR-3170 agomir

Sign In for Pricing
View Details
Hsa-miR-3170 agomir
HY-R00626A-02 20 nmol

Hsa-miR-3170 agomir

Sign In for Pricing
View Details
GLYATL2 siRNA (Human)
CRJ6438-01 15 nmol

GLYATL2 siRNA (Human)

Sign In for Pricing
View Details
GLYATL2 siRNA (Human)
CRJ6438-02 30 nmol

GLYATL2 siRNA (Human)

Sign In for Pricing
View Details
Gpc2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)
K4033807 1.0 µg DNA

Gpc2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

Sign In for Pricing
View Details
(+) -Isopulegol
MF-0002103-01 250 µg

(+) -Isopulegol

Sign In for Pricing
View Details